SCHEMBL22680471

SCHEMBL22680471

Bc1c(O)c(B)c2oc(C(C)O)c(C(=O)c3cc(Br)c(O)c(Br)c3)c2c1B

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EYA3 Q99504 4/20 0.54
▸ SLC22A12 Q96S37 12/20 0.40
▸ TTR P02766 5/20 0.40
▸ CYP2C19 P33261 2/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ EYA2 O00167 1/20 0.39
▸ ABCC4 O15439 1/20 0.39
▸ PLIN1 O60240 1/20 0.39
▸ NR1I2 O75469 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ ABCB11 O95342 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ ALB P02768 1/20 0.39
▸ ESR1 P03372 1/20 0.39
▸ NR3C1 P04150 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ PGR P06401 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20718288 0.94 EYA3 (0.55) EYA3SLC22A12TTRCYP2C19CYP2C9
SCHEMBL22680539 0.89 EYA3 (0.44) EYA3SLC22A12TTRCYP2C19CYP2C9
SCHEMBL20718531 0.87 EYA3 (0.51) EYA3SLC22A12TTRCYP2C19CYP2C9
SCHEMBL20718309 0.84 EYA3 (0.44) EYA3SLC22A12TTRCYP2C19CYP2C9
SCHEMBL20718353 0.83 EYA3 (0.43) EYA3SLC22A12TTRCYP2C19CYP2C9
SCHEMBL22072500 0.82 EYA3 (0.58) EYA3SLC22A12TTRCYP2C19CYP2C9
SCHEMBL24103744 0.81 EYA3 (0.42) EYA3SLC22A12TTRCYP2C19CYP2C9
SCHEMBL24102960 0.81 EYA3 (0.42) EYA3SLC22A12TTRCYP2C19CYP2C9
SCHEMBL25815944 0.79 SLC22A12 (0.56) EYA3SLC22A12TTRCYP2C19CYP2C9
SCHEMBL22680601 0.78 EYA3 (0.39) EYA3CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021252630-A1 METHODS FOR TREATING OR PREVENTING CHRONIC KIDNEY DISEASE ARTHROSI THERAPEUTICS, INC. (US) 2021-12-16 — — WO disclosed
WO-2020232156-A1 COMPOUND FOR TREATING GOUT OR HYPERURICEMIA ARTHROSI THERAPEUTICS, INC. (US) 2020-11-19 — — WO disclosed
Send feedback